MedPath
NMPA Approval

Measles and Mumps Combined Vaccine,Live

国药准字S20000028

April 26, 2020

Drug Information

麻疹腮腺炎联合减毒活疫苗

注射剂

复溶后每瓶0.5ml。每1次人用剂量为0.5ml,含麻疹活病毒应不低于3.0lgCCID50,含腮腺炎活病毒应不低于3.7lgCCID50。

生物制品

April 26, 2020

Company Information

Applicant Company

上海市长宁区延安西路1262号

Manufacturing Company

上海市奉贤区广丰路758号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

麻疹腮腺炎联合减毒活疫苗 - NMPA 批准文号 | MedPath